-
Study aim
-
To evaluate the effect of positive end expiratory pressure on ultrasonographic optic nerve sheath diameter, as a surrogate marker of intracranial pressure, in adults undergoing elective laparoscopic cholecystectomy under general anesthesia.
-
Design
-
Single center, parallel group, randomized controlled, double blind clinical trial with 50 participants allocated equally by computer generated block randomization using sealed envelopes.
-
Settings and conduct
-
The trial will be conducted at a tertiary hospital called "Iraqi hospital" in Kufa. Participants will undergo standard general anesthesia and laparoscopic cholecystectomy. Participants, outcome assessor, and data analyst will remain blinded. Group allocation will be concealed using sequentially numbered opaque sealed envelopes.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Adults aged 18 to 70 years, with American Society of Anesthesiologists physical status I to III, undergoing elective laparoscopic cholecystectomy. Exclusion criteria: ophthalmic disease, cerebrovascular disease, significant respiratory disease, pregnancy, inability to undergo optic nerve sheath ultrasonography, refusal to participate.
-
Intervention groups
-
Control group receives volume controlled ventilation with zero positive end expiratory pressure. Intervention group receives body mass index adjusted positive end expiratory pressure of 5, 8, or 10 centimeters of water.
-
Main outcome variables
-
Primary outcome is optic nerve sheath diameter measured by ultrasonography. Secondary outcomes are mean arterial pressure, heart rate, peak inspiratory pressure, plateau pressure, driving pressure, and their association with optic nerve sheath diameter.